Skeletalis

1 known investors

Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling. The company translates bone biology research into therapies designed to protect and rebuild bone.